Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicine, announced today the publication of foundational research demonstrating the power of its proprietary ...
To help with this transition, DCI has named long-time partner RiskScout as its preferred BSA/AML and Fraud vendor to bring advanced financial crime solutions to users. RiskScout, a financial ...
NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...
Completion of treatment for the first 45 patients on pace for Q1 2026 with initial unblinded data thereafter; blinded response activity tracking ...
Fintech law company Gofaizen & Sherle has announced the launch of the Crypto License Navigator, an interactive tool designed ...
Get the latest on Curis, Inc.’s Q3 2025 earnings, clinical trial milestones, and investment outlook in rare lymphoma and CLL.
Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, today announced its operating and financial results ...
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, ...
The UK Gambling Commission ( UKGC) has ordered NetBet Enterprises Limited, operator of netbet.co.uk, to pay £650,000 ...
Ireland has issued its first crypto enforcement action as Coinbase Europe admits flaws in monitoring 30 million transactions.
Researchers say the breakthrough is an important step forward in being able to carry out medical research without the use of animals.
In October 2025, the U.S. Food and Drug Administration (FDA) granted approval to multiple new cancer therapies and supportive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback